<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapy with RBC transfusions and rHuEPO for management of <z:hpo ids='HP_0001903'>anemia</z:hpo> in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> causes recurrent fluctuations in <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to elaborate a mathematical model for the interpretation of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> fluctuations and to correlate the resulting numerical parameter (Variaglobin Index) with quality of life and <z:mp ids='MP_0002899'>fatigue</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In 32 myelodysplastic patients, lower amplitude of the Variaglobin Index was found significantly correlated with a better quality of life and less <z:mp ids='MP_0002899'>fatigue</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The mathematical model proposed here makes it easy to monitor <z:hpo ids='HP_0001903'>anemia</z:hpo> in myelodysplastic patients and to adjust therapy accordingly </plain></SENT>
</text></document>